209 related articles for article (PubMed ID: 36210658)
21. A N0 Predicting Model for Sentinel Lymph Node Biopsy Omission in Early Breast Cancer Upstaged From Ductal Carcinoma in Situ.
Yoo TK; Kim SJ; Lee J; Lee SB; Lee SJ; Park HY; Park HK; Chae BJ; Eom YH; Kim HS; Song BJ
Clin Breast Cancer; 2020 Jun; 20(3):e281-e289. PubMed ID: 32147404
[TBL] [Abstract][Full Text] [Related]
22. Lymph Node and Distant Metastases in Phyllodes Tumor of the Breast.
Naal T; Saker S; Coldren D
Int J Surg Pathol; 2023 Aug; 31(5):761-764. PubMed ID: 36285397
[TBL] [Abstract][Full Text] [Related]
23. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
[TBL] [Abstract][Full Text] [Related]
24. Upstaging to invasive ductal carcinoma after mastectomy for ductal carcinoma in situ: predictive factors and role of sentinel lymph node biopsy.
Watanabe Y; Anan K; Saimura M; Koga K; Fujino M; Mine M; Tamiya S; Nishihara K; Nakano T; Mitsuyama S
Breast Cancer; 2018 Nov; 25(6):663-670. PubMed ID: 29786772
[TBL] [Abstract][Full Text] [Related]
25. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
[TBL] [Abstract][Full Text] [Related]
26. [Predictive factors of invasion with initial diagnosis of ductal carcinoma in situ based on core biopsy].
Kósa C; Garami Z; Dinya T; Fülöp B
Magy Seb; 2012 Aug; 65(4):218-21. PubMed ID: 22940391
[TBL] [Abstract][Full Text] [Related]
27. Ductal Carcinoma In Situ Simultaneously Involving the Breast and Epithelial Inclusions in an Ipsilateral Axillary Lymph Node.
Commander LA; Ollila DW; O'Connor SM; Hertel JD; Calhoun BC
Int J Surg Pathol; 2018 Sep; 26(6):564-568. PubMed ID: 29560779
[TBL] [Abstract][Full Text] [Related]
28. Prophylactic mastectomy in patients at high risk: is there a role for sentinel lymph node biopsy?
Murthy V; Chamberlain RS
Clin Breast Cancer; 2013 Jun; 13(3):180-7. PubMed ID: 23357305
[TBL] [Abstract][Full Text] [Related]
29. [Invasive Ductal Carcinoma within a Borderline Malignancy Phyllodes Tumor-A Case Report].
Maeda N; Yu X; Nabeya M; Suyama R; Suzuki N; Takeda S; Tamesa M; Nagashima Y; Kubo H; Yamamoto S; Nagano H
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1618-1620. PubMed ID: 38303360
[TBL] [Abstract][Full Text] [Related]
30. The role of sentinel node biopsy in ductal carcinoma in situ of the breast.
Polom K; Murawa D; Wasiewicz J; Nowakowski W; Murawa P
Eur J Surg Oncol; 2009 Jan; 35(1):43-7. PubMed ID: 18723312
[TBL] [Abstract][Full Text] [Related]
31. [A Case of a Malignant Phyllodes Tumor in the Breast with Lymph Node Metastasis].
Morisaki T; Noda S; Ishihara S; Asano Y; Kashiwagi S; Takashima T; Onoda N; Ohira M
Gan To Kagaku Ryoho; 2021 Mar; 48(3):437-439. PubMed ID: 33790180
[TBL] [Abstract][Full Text] [Related]
32. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
[TBL] [Abstract][Full Text] [Related]
33. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?
Cox CE; Nguyen K; Gray RJ; Salud C; Ku NN; Dupont E; Hutson L; Peltz E; Whitehead G; Reintgen D; Cantor A
Am Surg; 2001 Jun; 67(6):513-9; discussion 519-21. PubMed ID: 11409797
[TBL] [Abstract][Full Text] [Related]
34. Risk factor for axillary lymph node metastases in microinvasive breast cancer.
Ko BS; Lim WS; Kim HJ; Yu JH; Lee JW; Kwan SB; Lee YM; Son BH; Gong GY; Ahn SH
Ann Surg Oncol; 2012 Jan; 19(1):212-6. PubMed ID: 21633867
[TBL] [Abstract][Full Text] [Related]
35. Do not contemplate invasive surgery for ductal carcinoma in situ.
Zelis JJ; Sickle-Santanello BJ; Liang WC; Nims TA
Am J Surg; 2002 Oct; 184(4):348-9. PubMed ID: 12383899
[TBL] [Abstract][Full Text] [Related]
36. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
[TBL] [Abstract][Full Text] [Related]
37. Preoperatively diagnosed ductal carcinoma in situ: risk prediction of invasion and effects on axillary management.
Sato Y; Kinoshita T; Suzuki J; Jimbo K; Asaga S; Hojo T; Yoshida M; Tsuda H
Breast Cancer; 2016 Sep; 23(5):761-70. PubMed ID: 26324092
[TBL] [Abstract][Full Text] [Related]
38. A case report of a patient with ductal carcinoma and a malignant phyllodes tumor in situ in 2 separate breasts.
Li C; Zhang C
Medicine (Baltimore); 2023 Dec; 102(48):e36405. PubMed ID: 38050272
[TBL] [Abstract][Full Text] [Related]
39. Necessity of sentinel lymph node biopsy in ductal carcinoma in situ patients: a retrospective analysis.
Shin YD; Lee HM; Choi YJ
BMC Surg; 2021 Mar; 21(1):159. PubMed ID: 33752671
[TBL] [Abstract][Full Text] [Related]
40. [Influence of the number of removed axillary lymph nodes on the prognosis of node-negative primary breast cancer].
Wang HY; Dong HT; Liu Q; Xing P; Li JG
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):457-60. PubMed ID: 22967449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
